Investor Info
Our Presentation
Cap Table
MustGrow is publicly traded (CSE:MGRO) (OTCQX:MGROF) (FRA:0C0) agricultural biotech company focused on providing natural science-based biological solutions for high value crops, including fruit & vegetable cultivation.
| CAPITAL STRUCTURE | |
|---|---|
| Basic Shares Outstanding | 46,189,177 |
| Options | 3,725,000 |
| Warrants | 4,717,000 |
| Fully-Diluted Shares Outstanding | 55,666,177 |
| Insider Ownership (~17%) | 7,971,647 |
| CSE Average Volume (3 month) | 85,200 |
| Previous Capital Spent (C$MM) | $15.0 |
| Cash Position (C$MM) | $9.8 |
| Debt (C$MM) | $1.0 |
Natural Technology Platform with the Efficacy of Synthetic Chemicals
- 100% owned patented mustard-derived technology; harnessing the natural defense mechanism of the mustard seed.
- MustGrow’s natural biological solutions to replace synthetic chemicals used in high value crops such as fruit & vegetables and other industries.
- Regulatory agencies are restricting or banning existing synthetic chemistries leaving limited alternatives.
- Consumers are demanding healthy, natural and organic products.
- Producers want to protect their crops with bilogicals but only if they work -- may bilogicals have as today not met performance expectations.
- Agchem companies are actively investing in more sustainable natural technologies to replace or compliment synthetic chemicals.
- Sustainable farming practices are critical to feed a growing global
population on a finite amount of land.
Technology Platform with Application in Many Markets
-
Preplant Soil Biofumigant for multiple crops such as fruit, vegetable, turf and ornamental crops.
-
Bioherbicide with unique mode of action for organic acres, home & garden and jurisdictions where glyphosate is out of favor or banned.
-
Postharvest Biopesticide for storage and food preservation (F&V, bulk grain, shipping containers and food borne pathogens).
Technology Pipeline
FINANCIAL STATEMENTS
2021 Financials
2020 Financials
Q1-2021
Q2-2021
Q1-2020
News Releases
MustGrow Biologics Closes $7.1 Million Private Placement
MustGrow Biologics Closes $7.1 Million Private Placement SASKATOON, Saskatchewan, Canada, October 7, 2021 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce the closing of its previously-announced non-brokered private...
MustGrow Biologics Upsizes Private Placement to $6.9 Million; Gluskin Invests $1 Million
MustGrow Biologics Upsizes Private Placement to $6.9 Million; Gluskin Invests $1 Million SASKATOON, Saskatchewan, Canada, September 29, 2021 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce it has upsized its...
MustGrow Biologics Arranges $2 Million Equity Private Placement
MustGrow Biologics Arranges $2 Million Equity Private Placement SASKATOON, Saskatchewan, Canada, September 13, 2021 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce a non-brokered private placement (the “Private...